F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.12 EUR -1.75%
Market Cap: 414.9m EUR

Relative Value

The Relative Value of one FLB stock under the Base Case scenario is 0.86 EUR. Compared to the current market price of 1.12 EUR, Fluidigm Corp is Overvalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FLB Relative Value
Base Case
0.86 EUR
Overvaluation 23%
Relative Value
Price
F
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
36
vs Industry
61
Median 3Y
1.9
Median 5Y
2.5
Industry
4
Forward
2.9
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-3.8
Industry
31.4
Forward
-4.8
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-4.7
Industry
19.5
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-4.4
Industry
33.5
vs History
65
vs Industry
76
Median 3Y
1
Median 5Y
1.4
Industry
2.7
vs History
58
vs Industry
81
Median 3Y
1
Median 5Y
2.1
Industry
3.8
Forward
1.4
vs History
60
vs Industry
81
Median 3Y
2.1
Median 5Y
4
Industry
8.4
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-3.2
Industry
17.5
Forward
-3.5
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-2.8
Industry
23.6
Forward
-2.1
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-2.7
Industry
18.1
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-2.5
Industry
23.5
vs History
55
vs Industry
82
Median 3Y
0.5
Median 5Y
1
Industry
2.4

Multiples Across Competitors

FLB Competitors Multiples
Fluidigm Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Fluidigm Corp
F:FLB
424.6m EUR 2.9 -3.7 -2.2 -1.9
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 397.5 3 841.2 1 346.7 2 746.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
160.6B USD 3.7 24.6 17.2 23.7
US
Danaher Corp
NYSE:DHR
141.5B USD 5.9 37.6 20.7 30.1
KR
Samsung Biologics Co Ltd
KRX:207940
73.2T KRW 14.9 57.2 33.2 46.2
CH
Lonza Group AG
SIX:LONN
39.5B CHF 6 62 22.7 35.4
US
Agilent Technologies Inc
NYSE:A
34.1B USD 5.1 29.2 19.8 23.4
CN
WuXi AppTec Co Ltd
SSE:603259
231.5B CNY 5.7 20.7 20.1 20.1
US
IQVIA Holdings Inc
NYSE:IQV
27.9B USD 1.8 20.9 11.5 17.2
US
Mettler-Toledo International Inc
NYSE:MTD
24.8B USD 6.5 29.2 21.7 24.1
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.1B EUR 6.7 93.4 29.9 52.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
F
Fluidigm Corp
F:FLB
Average EV/EBITDA: 154.4
Negative Multiple: -2.2
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 346.7
7%
192.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
17.2
6%
2.9
US
Danaher Corp
NYSE:DHR
20.7
7%
3
KR
Samsung Biologics Co Ltd
KRX:207940
33.2
17%
2
CH
Lonza Group AG
SIX:LONN
22.7
18%
1.3
US
Agilent Technologies Inc
NYSE:A
19.8
10%
2
CN
WuXi AppTec Co Ltd
SSE:603259
20.1
24%
0.8
US
IQVIA Holdings Inc
NYSE:IQV
11.5
9%
1.3
US
Mettler-Toledo International Inc
NYSE:MTD
21.7
4%
5.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
29.9
20%
1.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
F
Fluidigm Corp
F:FLB
Average EV/EBIT: 302
Negative Multiple: -1.9
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 746.9
32%
85.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
23.7
20%
1.2
US
Danaher Corp
NYSE:DHR
30.1
17%
1.8
KR
Samsung Biologics Co Ltd
KRX:207940
46.2
22%
2.1
CH
Lonza Group AG
SIX:LONN
35.4
22%
1.6
US
Agilent Technologies Inc
NYSE:A
23.4
15%
1.6
CN
WuXi AppTec Co Ltd
SSE:603259
20.1
16%
1.3
US
IQVIA Holdings Inc
NYSE:IQV
17.2
15%
1.1
US
Mettler-Toledo International Inc
NYSE:MTD
24.1
6%
4
FR
Sartorius Stedim Biotech SA
PAR:DIM
52.8
31%
1.7